VALNEVA financials
VALNEVA
969500DIVIP5VKNW4948 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €174.7M | €169.6M |
| Cost of sales | €107.1M | €98.5M |
| Operating profit (EBIT) | -€82.1M | €13.3M |
| Finance costs | €41.9M | €24.0M |
| Profit before tax | -€114.1M | -€11.5M |
| Income tax expense | €1.1M | €761.0K |
| Profit for the year | -€115.2M | -€12.2M |
| Total comprehensive income | -€114.6M | -€13.5M |
| Per share | ||
| Basic EPS | €-0.68 | €-0.08 |
| Diluted EPS | €-0.68 | €-0.08 |
| Free cash flow / share | €-0.34 | €-0.53 |
| Cash flow statement | ||
| Cash generated from operations | -€50.7M | -€65.7M |
| Net cash from operating activities | -€52.9M | -€67.2M |
| Net cash from investing activities | -€1.7M | €76.9M |
| Purchase of PP&E (capex) | €4.4M | €13.9M |
| Purchase of intangibles | €61.0K | €2.6M |
| Net cash from financing activities | -€621.0K | €30.7M |
| Proceeds from borrowings | €174.4M | -€34.0K |
| Repayments of borrowings | €171.6M | €3.7M |
| Lease liability payments | €2.7M | €2.7M |
| Net change in cash | -€55.2M | €40.4M |
| Balance sheet | ||
| Total assets | €398.8M | €500.0M |
| Non-current assets | €176.3M | €201.0M |
| Property, plant & equipment | €119.5M | €138.9M |
| Right-of-use assets | €18.6M | €19.2M |
| Current assets | €222.5M | €299.0M |
| Inventories | €50.2M | €53.7M |
| Trade & other receivables | €27.8M | €35.2M |
| Cash & equivalents | €109.7M | €168.3M |
| Total equity | €106.2M | €181.3M |
| — attributable to owners | €106.2M | €181.3M |
| Non-current liabilities | €199.3M | €204.2M |
| Long-term borrowings | €161.3M | €166.5M |
| Lease liabilities (non-current) | €25.3M | €26.4M |
| Current liabilities | €93.3M | €114.6M |
| Current portion of long-term borrowings | €17.9M | €20.9M |
| Lease liabilities (current) | €2.7M | €2.5M |
| Trade & other payables | €24.5M | €35.5M |
| Deferred tax liabilities | €4.4M | €4.2M |
| Derived metrics | ||
| Free cash flow | -€57.3M | -€81.1M |
| Operating margin | -47.0% | 7.9% |
| Net margin | -66.0% | -7.2% |
| Return on equity | -108.5% | -6.8% |
| Cash conversion ratio | 0.46× | 5.49× |
| Capex coverage | -11.97× | -4.85× |
| Other reported items | ||
| Current Contract Liabilities | €432.0K | €3.0M |
| Current Provisions | €11.7M | €6.7M |
| Current Tax Liabilities Current | €1.0K | €1.7M |
| Deferred Tax Assets | €8.3M | €9.6M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€3.4M | €1.8M |
| Equity and Liabilities | €398.8M | €500.0M |
| Finance Income | €2.6M | €2.4M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | €7.2M | -€3.2M |
| General and Administrative Expense | €37.3M | €42.8M |
| Income Taxes Paid Refund Classified As Operating Activities | €2.2M | €1.5M |
| Increase Decrease In Working Capital | €1.5M | €11.4M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Intangible Assets Other Than Goodwill | €22.3M | €25.3M |
| Interest Paid Classified As Financing Activities | €30.7M | €20.0M |
| Interest Received Classified As Investing Activities | €1.8M | €2.4M |
| Issue of Equity | €27.4M | €61.2M |
| Issued Capital | €26.0M | €24.4M |
| Liabilities | €292.7M | €318.8M |
| Noncurrent Provisions | €1.4M | €546.0K |
| Other Comprehensive Income | €588.0K | -€1.3M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €520.0K | -€1.3M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €68.0K | €49.0K |
| Other Noncurrent Assets | €7.6M | €8.0M |
| Other Noncurrent Liabilities | €246.0K | €46.0K |
| Other Reserves | €83.3M | €73.2M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €128.0K | €165.0K |
| Research and Development Expense | €85.3M | €74.1M |
| Retained Earnings Excluding Profit Loss For Reporting Period | -€563.9M | -€551.7M |
| Retained Earnings Profit Loss For Reporting Period | -€115.2M | -€12.2M |
| Revenue From Contracts With Customers | €157.9M | €163.3M |
| Share Issue Related Cost | €1.2M | €4.0M |
| Share Premium | €675.9M | €647.6M |
Every line item above is a fact tagged in VALNEVA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.